High levels of lipoprotein(a) - assessment and treatment. / Høyt nivå av lipoprotein(a) utredning og behandling.
Tidsskr Nor Laegeforen
; 142(1)2023 01 17.
Article
em En, Nor
| MEDLINE
| ID: mdl-36655975
ABSTRACT
Approximately 5 % of the population have highly elevated levels of lipoprotein(a) (Lp(a)), which is a genetically determined risk factor for cardiovascular disease. Measuring lipoprotein(a) can improve cardiovascular risk stratification and have consequences for preventive measures. Treatment is targeted at reducing modifiable cardiovascular risk factors, but Lp(a)-lowering drugs are being trialled. This article reviews the management of lipoprotein(a) in clinical practice.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Lipoproteína(a)
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
/
Nor
Revista:
Tidsskr Nor Laegeforen
Ano de publicação:
2023
Tipo de documento:
Article